Searched over 200M research papers
5 papers analyzed
These studies suggest that ACE blood tests can provide insights into personalized medicine, tissue-specific ACE properties, atrial fibrillation risk, angiotensin II levels, free bilirubin levels, and extrapulmonary sarcoidosis involvement.
20 papers analyzed
The angiotensin-converting enzyme (ACE) plays a crucial role in blood pressure regulation and vascular remodeling. ACE blood tests are used to measure the enzyme's activity in the blood, which can provide valuable insights into various health conditions, including cardiovascular diseases and granulomatous diseases like sarcoidosis .
Conformational fingerprinting is a novel approach that uses monoclonal antibodies (mAbs) to detect subtle conformational changes in ACE. This method is highly sensitive and can identify differences in ACE conformation due to mutations, glycosylation variations, and the presence of inhibitors or effectors. The conformational fingerprinting technique has proven to be more sensitive than traditional kinetic assays for detecting ACE inhibitors in plasma.
ACE phenotyping reveals significant differences in ACE activity and conformation across different tissues. For instance, ACE activity in heart tissues is significantly lower than in lung tissues, and the conformational fingerprint of heart ACE differs from that of lung ACE due to tissue-specific glycosylation patterns. These differences are crucial for developing targeted therapies and diagnostic tools, such as mAbs that can distinguish between heart and lung ACEs, potentially predicting conditions like atrial fibrillation.
ACE phenotyping can identify individuals with conformationally altered ACE, which is clinically significant. For example, certain conformational changes in ACE are associated with increased angiotensin I hydrolysis and elevated levels of endogenous ACE inhibitors in plasma. This type of screening can help in the early detection of cardiovascular risks and other conditions, making it a valuable tool for personalized medicine.
Research has shown that plasma ACE activity is influenced by both ACE insertion/deletion (I/D) polymorphism and ABO blood groups. Different blood groups exhibit varying levels of ACE activity, with blood group B showing the highest activity and group A the lowest. Additionally, the I/D polymorphism significantly affects ACE activity, with the DD genotype showing the highest activity. These factors together account for a notable portion of the variability in plasma ACE activity, highlighting the importance of considering genetic and blood group factors in ACE-related studies.
Conformational fingerprinting of ACE has shown potential in diagnosing and monitoring sarcoidosis. Patients with sarcoidosis exhibit distinct conformational fingerprints of ACE in both blood and tissue samples, which can help in identifying extrapulmonary involvement of the disease. This method could serve as a biomarker for sarcoidosis, providing a non-invasive diagnostic tool with significant clinical relevance.
The ACE blood test, enhanced by techniques like conformational fingerprinting and phenotyping, offers a powerful tool for diagnosing and monitoring various health conditions. By understanding tissue-specific differences, genetic influences, and the role of blood groups, healthcare providers can better tailor treatments and improve patient outcomes. The ongoing research and development in this field hold promise for more accurate and personalized medical care.
Most relevant research papers on this topic